Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 97 (4) , 439-444
- https://doi.org/10.1053/rmed.2002.1444
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutolThorax, 2001
- Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis.Thorax, 1996
- Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.Thorax, 1994
- Mycobacteria and the new quinolonesAntimicrobial Agents and Chemotherapy, 1989
- Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.Thorax, 1987
- Pulmonary infection with mycobacterium xenopi: review of treatment and response.Thorax, 1984
- Clinical review of pulmonary disease caused by Mycobacterium xenopi.Thorax, 1983
- A system for the examination of tubercle bacilli and other mycobacteriaTubercle, 1976
- Radiology in epidemiological studies and some therapeutic trials.BMJ, 1966
- The design of sensitivity tests on tubercle bacilliTubercle, 1961